Surabhi Srivastava holds a PhD from the National Institute of Immunology, New Delhi and is a molecular biologist combining over a decade of scientific research and management at the CSIR-Centre for Cellular and Molecular Biology. She is currently the chief scientific officer at the Tata Institute for Genetics and Society, Bengaluru.
Cell and gene therapies directly target faulty genes or cells offering the hope of shifting care from lifelong maintenance to potentially durable, one-time interventions. Can India build an ecosystem…